- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Rheumatoid arthritis, or RA, is an autoimmune disease. It is an inflammatory condition, that causes painful swelling and that can affect more parts of the body than just joints. In some cases, this condition can damage a wide range of body systems, including skin, eyes, lungs, heart and blood vessels.
Showing 1–12 of 40 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
2018.05 |
145,00 € |
||
CD20 |
Biosimilar , Monoclonal Antibody |
Ruxience® |
10 mg/mL |
– |
2 mg |
-80 °C |
2025.12 |
202,00 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
4 mg |
-80°C |
2026.04 |
202,00 € |
||
CD20 |
Biosimilar , Monoclonal Antibody |
Rixathon® |
10 mg/mL |
– |
2 mg |
-80 °C |
2026.03 |
245,00 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
2021.10 |
139,00 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
2018.05 |
139,00 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
2019.03 |
139,00 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
2019.05 |
139,00 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
2 mg |
-80°C |
2020.03 |
139,00 € |
||
IL-6 receptor |
Monoclonal Antibody |
RoActemra® |
20 mg/mL |
– |
4 mg |
-80°C |
2025.05 |
245,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany